In vitro evaluation of synergism or antagonism with combinations of new cytotoxic agents

被引:35
作者
Budman, DR [1 ]
Calabro, A [1 ]
Kreis, W [1 ]
机构
[1] NYU, Sch Med, N Shore Univ Hosp, Dept Med,Don Monti Div Oncol, Manhasset, NY 11030 USA
关键词
etoposide; gemcitabine; median effect analysis; paclitaxel; vinorelbine;
D O I
10.1097/00001813-199809000-00005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
New cytotoxics with significant activity both in preclinical and clinical situations continued to be applied in the clinic by empiric means. The use of defined cell lines allows unanticipated antagonism between agents to be identified and to suggest synergistic combinations which need to be tested. By means of a semi-automated MTT assay and median effect analysis, we have identified antagonism in two couplets being evaluated in the clinic: etoposide with paclitaxel and vinorelbine with gemcitabine. Optimal use of these agents in man may require spacing these agents in time to prevent an adverse drug interaction between the agents which may diminish the potential response rate. [(C) 1998 Lippincott Williams & Wilkins.].
引用
收藏
页码:697 / 702
页数:6
相关论文
共 36 条
[1]   THE EFFECT OF ANTICANCER DRUG SEQUENCE IN EXPERIMENTAL COMBINATION CHEMOTHERAPY [J].
ADEL, AL ;
DORR, RT ;
LIDDIL, JD .
CANCER INVESTIGATION, 1993, 11 (01) :15-24
[2]  
BOROS L, 1995, SEMIN ONCOL, V22, P28
[3]   Vinorelbine (Navelbine(R)): A third-generation vinca alkaloid [J].
Budman, DR .
CANCER INVESTIGATION, 1997, 15 (05) :475-490
[4]  
BUDMAN DR, 1996, P AM ASSOC CANC RES, V37, pA2493
[5]  
BUDMAN DR, 1996, CHEMOTHERAPY SOURCEB, P479
[6]  
Carmichael J, 1996, SEMIN ONCOL, V23, P77
[7]  
Chang AY, 1996, SEMIN ONCOL, V23, P74
[8]  
CHOU J, 1987, EUR J BIOCH
[9]   GENERALIZED EQUATIONS FOR THE ANALYSIS OF INHIBITIONS OF MICHAELIS-MENTEN AND HIGHER-ORDER KINETIC SYSTEMS WITH 2 OR MORE MUTUALLY EXCLUSIVE AND NON-EXCLUSIVE INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1981, 115 (01) :207-216
[10]   QUANTITATION OF THE SYNERGISTIC INTERACTION OF EDATREXATE AND CISPLATIN INVITRO [J].
CHOU, TC ;
TAN, QH ;
SIROTNAK, FM .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 31 (04) :259-264